Related Experiment Video
Updated: Oct 8, 2025

09:14
Modifying Baculovirus Expression Vectors to Produce Secreted Plant Proteins in Insect Cells
Published on: August 20, 2018
11.7K
Innovations in the Insect Cell Expression System for Industrial Recombinant Vaccine Antigen Production
1NextWaveBio, LLC, East Haven, CT 06512, USA.
Vaccines
|December 28, 2021
Summary
Insect cell expression systems offer a biosecure platform for vaccine production, but face challenges in rapid, large-scale antigen manufacturing. Innovations in vector development, cell engineering, and bioprocessing aim to enhance production and accelerate timelines for future pandemic preparedness.
Area of Science:
- Biotechnology
- Vaccine Development
- Protein Expression
Background:
- Insect cell expression systems are a preferred biosecurity strategy for vaccine production, exemplified by Flublok® (recombinant influenza vaccine).
- Existing large-scale capacity offers potential for producing diverse antigens, but limitations hinder rapid response to pandemics like SARS-CoV-2.
- Key challenges include achieving adequate quantities of purified antigen in accelerated timelines.
Purpose of the Study:
- To review recent technological innovations for enhancing recombinant protein production in insect cells.
- To identify strategies for shortening vaccine development and manufacturing timelines.
- To address limitations of insect cell expression systems for rapid pandemic response.
Main Methods:
- Review of recent advancements in vector development for improved protein expression.
- Analysis of cell line engineering techniques to boost recombinant protein yields.
- Evaluation of bioprocessing optimization strategies for increased product concentration.
- Assessment of process standardization for accelerated manufacturing.
Main Results:
- Innovations in vector design and cell engineering can significantly increase recombinant protein production levels.
- Optimized bioprocessing methods offer opportunities to enhance product concentration.
- Standardization of manufacturing processes can shorten development timelines for vaccine candidates.
- Technological advancements are crucial for overcoming current limitations in rapid antigen production.
Conclusions:
- Insect cell expression systems require technological enhancements to meet the demands of rapid pandemic response.
- Further innovation in protein production and process acceleration is vital for leveraging this platform effectively.
- Addressing current limitations will ensure recombinant antigens play a critical role in combating future pandemics.

